Cancer chemotherapy with lipid-based nanocarriers - PubMed (original) (raw)
Review
Cancer chemotherapy with lipid-based nanocarriers
Donghua Liu et al. Crit Rev Ther Drug Carrier Syst. 2010.
Abstract
Nanotechnology has a profound effect on many areas of scientific research. Having grown exponentially, the focus of nanotechnology has been on therapeutic activity, such as cancer treatment. Lipid-based nanocarriers have attracted increasing scientific and commercial attention in the last few years as alternative carriers for the delivery of anticancer drugs. Lipid-based nanocarriers have played significant roles in the formulation of anticancer drugs to improve therapeutics. Shortcomings frequently encountered with anticancer compounds, such as poor solubility, normal tissue toxicity, poor specificity and stability, as well as the high incidence rate of drug resistance, are expected to be overcome through use of lipid-based nanocarriers. In this review, the advantages and methods of using nanocarriers to improve cancer treatment efficiency will be discussed. In addition, types of lipid-based nanocarriers are presented and hotspots in research are highlighted. It is anticipated that, in the near future, lipid-based nanocarriers will be further improved to deliver cytotoxic anticancer compounds in a more efficient, specific and safe manner.
Similar articles
- Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.
Wong HL, Bendayan R, Rauth AM, Li Y, Wu XY. Wong HL, et al. Adv Drug Deliv Rev. 2007 Jul 10;59(6):491-504. doi: 10.1016/j.addr.2007.04.008. Epub 2007 May 1. Adv Drug Deliv Rev. 2007. PMID: 17532091 Review. - Nanostructured lipid carriers: a potential drug carrier for cancer chemotherapy.
Selvamuthukumar S, Velmurugan R. Selvamuthukumar S, et al. Lipids Health Dis. 2012 Nov 20;11:159. doi: 10.1186/1476-511X-11-159. Lipids Health Dis. 2012. PMID: 23167765 Free PMC article. Review. - Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E, Fernández-Medarde A. Pérez-Herrero E, et al. Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23. Eur J Pharm Biopharm. 2015. PMID: 25813885 Review. - Hydrophobic ion pairing as a strategy to improve drug encapsulation into lipid nanocarriers for the cancer treatment.
Oliveira MS, Goulart GCA, Ferreira LAM, Carneiro G. Oliveira MS, et al. Expert Opin Drug Deliv. 2017 Aug;14(8):983-995. doi: 10.1080/17425247.2017.1266329. Epub 2016 Dec 14. Expert Opin Drug Deliv. 2017. PMID: 27892713 Review. - Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
Edis Z, Wang J, Waqas MK, Ijaz M, Ijaz M. Edis Z, et al. Int J Nanomedicine. 2021 Feb 17;16:1313-1330. doi: 10.2147/IJN.S289443. eCollection 2021. Int J Nanomedicine. 2021. PMID: 33628022 Free PMC article. Review.
Cited by
- pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluation.
Kim CH, Sa CK, Goh MS, Lee ES, Kang TH, Yoon HY, Battogtokh G, Ko YT, Choi YW. Kim CH, et al. Int J Nanomedicine. 2018 Oct 23;13:6661-6675. doi: 10.2147/IJN.S184355. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30425481 Free PMC article. - Application of Various Types of Liposomes in Drug Delivery Systems.
Alavi M, Karimi N, Safaei M. Alavi M, et al. Adv Pharm Bull. 2017 Apr;7(1):3-9. doi: 10.15171/apb.2017.002. Epub 2017 Apr 13. Adv Pharm Bull. 2017. PMID: 28507932 Free PMC article. - Comparison of injectable doxorubicin & its nanodrug complex chemotherapy for the treatment of 4-nitroquinoline-1-oxide induced oral squamous cell carcinoma in rats.
Khiavi MM, Abdal K, Abbasi MM, Hamishehkar H, Aghbali AA, Salehi R, Sina M, Abdollahi B, Fotohi S. Khiavi MM, et al. Indian J Med Res. 2017 Jan;145(1):112-117. doi: 10.4103/ijmr.IJMR_542_14. Indian J Med Res. 2017. PMID: 28574023 Free PMC article. - Drug-targeting in combined cancer chemotherapy: tumor growth inhibition in mice by association of paclitaxel and etoposide with a cholesterol-rich nanoemulsion.
Kretzer IF, Maria DA, Maranhão RC. Kretzer IF, et al. Cell Oncol (Dordr). 2012 Dec;35(6):451-60. doi: 10.1007/s13402-012-0104-6. Epub 2012 Oct 3. Cell Oncol (Dordr). 2012. PMID: 23055341 - Drug delivery systems and combination therapy by using vinca alkaloids.
Lee CT, Huang YW, Yang CH, Huang KS. Lee CT, et al. Curr Top Med Chem. 2015;15(15):1491-500. doi: 10.2174/1568026615666150414120547. Curr Top Med Chem. 2015. PMID: 25877096 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources